Littérature scientifique

A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis

Revue : American Journal of Obstetrics & Gynecology, December 2017, Volume 217, Issue 6, Pages 678.e1–678.e9

Auteurs : Jane R. Schwebke, Franklin G. Morgan Jr., William Koltun, Paul Nyirjesy

DOI : 10.1016/j.ajog.2017.08.017